Kirsten M. Timms - Concepedia

Author

Kirsten M. Timms

Also Known As

K M Timms, K Timms, K. M. Timms, K. Timms, K.M Timms, K.M. Timms, Kirsten M Timms, Kirsten M. TIMMS, Kirsten M. Timms, Kirsten Timms

175

Publications

11.6K

Citations

H-Index

Concepts

All Affiliations

Myriad Genetics The University of Texas MD Anderson Cancer Center Baylor College of Medicine Dana-Farber Cancer Institute AstraZeneca (United Kingdom)

About

Kirsten M. Timms is an author at Myriad Genetics specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	35	4.3K
2	Natural Sciences	5	5	98
3	Health Sciences	4	4	73
4	Public Health	1	1	25
5	Social Sciences	1	1	31

Kirsten M. Timms

Publications

11.4K

Citations

H-Index

Page 1

	Year	Citations
The DNA sequence of the human X chromosome Mark T. Ross, Darren Grafham, Alison J. Coffey, Nature ChromatinDnaGeneticsChromosome BiologyMolecular Genetics	2005	1.2K
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Melinda L. Telli, Kirsten M. Timms, Julia Reid, Clinical Cancer Research	2016	1.1K
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial Andrew Tutt, Holly Tovey, Maggie C.U. Cheang, Nature Medicine Tnt TrialBreast OncologyMedicinePathologyBreast Cancer	2018	862
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer Victor Abkevich, Kirsten M. Timms, Bryan T. Hennessy, British Journal of Cancer	2012	831
Incidence and Outcome of <i>BRCA</i> Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer Ana M. González-Angulo, Kirsten M. Timms, Shuying Liu, Clinical Cancer Research	2011	598
Frequency of mutations in individuals with breast cancer referred for <scp><i>BRCA</i></scp><i>1</i> and <scp><i>BRCA</i></scp><i>2</i> testing using next‐generation sequencing with a 25‐gene panel Nadine Tung, Chiara Battelli, Brian Allen, Cancer	2014	430
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer Steven J. Isakoff, Erica L. Mayer, Lei He, Journal of Clinical Oncology	2015	412
Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis Francesca Capon, Paola Di Meglio, Joanna Szaub, Human Genetics InflammationCytokineSequence VariantsImmunologyImmune Regulation	2007	411
Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes Kirsten M. Timms, Victor Abkevich, Elisha Hughes, Breast Cancer Research	2014	402
Somatic Mutations in <i>BRCA1</i> and <i>BRCA2</i> Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer Bryan T. Hennessy, Kirsten M. Timms, Mark Carey, Journal of Clinical Oncology	2010	368

Page 1